Immunocore is a leading T cell receptor (TCR) biotechnology company working to create first-in-class biological therapies to address unmet patient needs in oncology as well as infectious and autoimmune diseases. See our community guidelines: http://bit.ly/2kFA8hr
View Top Employees from Immunocore| Website | http://www.immunocore.com |
| Ticker | IMCR |
| Revenue | $49.9 million |
| Funding | $822.1 million |
| Employees | 521 (492 on RocketReach) |
| Founded | 2008 |
| Phone | +44 1235 438600 |
| Technologies |
JavaScript,
HTML,
PHP
+43 more
(view full list)
|
| Industry | Biotechnology Research, Business Services General, Biotechnology, Pharmaceutical, Biotechology, Business Services, Science and Engineering, Medical, Immunocology, Health Care |
| Web Rank | 2 Million |
| Keywords | Oncology, Therapeutic Activities |
| Competitors | Adaptimmune, Autolus Ltd., Bicycle Therapeutics, Kymab Ltd, Roivant Sciences |
| SIC | SIC Code 283 Companies, SIC Code 28 Companies |
| NAICS | NAICS Code 325 Companies, NAICS Code 3254 Companies, NAICS Code 32541 Companies, NAICS Code 32 Companies |
Looking for a particular Immunocore employee's phone or email?
Immunocore Questions
The Immunocore annual revenue was $49.9 million in 2024.
Bahija Jallal is the CEO of Immunocore.
492 people are employed at Immunocore.
The NAICS codes for Immunocore are [325, 3254, 32541, 32].
The SIC codes for Immunocore are [283, 28].
Top Immunocore Employees
-
25
-
5+5+
-
ViewBrian Di Donato
Chief Financial Officer and Head of Strategy at Immunocore
Philadelphia, PA, US41 -
1
-
5+4
-
35
-
View
Mohammed Dar
Chief Medical Officer and Head of Clinical Development at Immunocore
Philadelphia, PA, US52
Related Companies
